Stock Scorecard



Stock Summary for Clover Health Investments Corp - Class A (CLOV) - $4.74 as of 10/22/2026 7:33:57 AM EST

Total Score

8 out of 30

Safety Score

28 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CLOV

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CLOV

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CLOV

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CLOV

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CLOV (28 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 1
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for CLOV

Clover Health CEO Karen Soares sells $68,669 in company stock By Investing.com 10/21/2026 2:39:00 AM
Medicare Advantage CEO sells 4,066 Clover Health (CLOV) shares under a trading plan. 10/20/2026 8:41:00 PM
Clover Health tops Medicare Advantage ratings in NJ, GA, and SC for 2027, excelling in care continuity and prevention. 10/19/2026 9:11:00 PM
To cover vesting taxes, Clover Health (CLOV) CEO sells 62,176 shares. 10/19/2026 8:11:00 PM
A proposed $21K share sale would cover stock-vesting taxes for a Clover Health (CLOV) officer. 10/15/2026 11:41:00 PM
To cover taxes, a Clover Health (CLOV) officer proposes selling 17,858 shares valued at $83.6K. 10/15/2026 11:11:00 PM
Tax withholding prompts a proposed 14,341-share sale by Clover Health (CLOV) officer Karen M. Soares. 10/15/2026 11:11:00 PM
To cover taxes, Clover Health (CLOV) officer Andrew Toy proposes selling 60,765 shares. 10/15/2026 11:11:00 PM
Weekly Recap: 5.0/4.5 CMS 2027 star ratings and Q3 2026 results webcast 10/13/2026 6:43:00 AM
Under a trading plan, Jamie L. Reynoso sells Clover Health (CLOV) shares at $4.63 on average. 10/8/2026 1:40:00 PM

Financial Details for CLOV

Company Overview

Ticker CLOV
Company Name Clover Health Investments Corp - Class A
Country USA
Description Clover Health Investments, Corp. The company is headquartered in Franklin, Tennessee.
Sector Name HEALTHCARE
Industry Name HEALTHCARE PLANS
Most Recent Quarter 6/30/2026
Next Earnings Date 11/4/2026

Stock Price History

Last Day Price 4.74
Price 4 Years Ago 0.93
Last Day Price Updated 10/22/2026 7:33:57 AM EST
Last Day Volume 3,503,573
Average Daily Volume 4,502,737
52-Week High 5.59
52-Week Low 1.58
Last Price to 52 Week Low 200.00%

Valuation Measures

Trailing PE N/A
Industry PE 29.17
Sector PE 46.63
5-Year Average PE -7.11
Free Cash Flow Ratio 10.30
Industry Free Cash Flow Ratio 9.23
Sector Free Cash Flow Ratio 28.54
Current Ratio Most Recent Quarter 1.50
Total Cash Per Share 0.46
Book Value Per Share Most Recent Quarter 0.71
Price to Book Ratio 6.45
Industry Price to Book Ratio 3.43
Sector Price to Book Ratio 11.36
Price to Sales Ratio Twelve Trailing Months 0.95
Industry Price to Sales Ratio Twelve Trailing Months 0.64
Sector Price to Sales Ratio Twelve Trailing Months 22.27
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 435,441,000
Market Capitalization 2,063,990,340
Institutional Ownership 33.94%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -98.91%
Reported EPS 12 Trailing Months -0.05
Reported EPS Past Year 0.13
Reported EPS Prior Year -0.07
Net Income Twelve Trailing Months -18,362,000
Net Income Past Year -85,549,000
Net Income Prior Year -43,009,000
Quarterly Revenue Growth YOY 55.60%
5-Year Revenue Growth 23.39%
Operating Margin Twelve Trailing Months 3.77%

Balance Sheet

Total Cash Most Recent Quarter 198,837,000
Total Cash Past Year 78,301,000
Total Cash Prior Year 194,543,000
Net Cash Position Most Recent Quarter 178,837,000
Net Cash Position Past Year 58,301,000
Long Term Debt Past Year 20,000,000
Long Term Debt Prior Year 20,000,000
Total Debt Most Recent Quarter 20,000,000
Equity to Debt Ratio Past Year 0.94
Equity to Debt Ratio Most Recent Quarter 0.95
Total Stockholder Equity Past Year 308,704,000
Total Stockholder Equity Prior Year 341,143,000
Total Stockholder Equity Most Recent Quarter 376,257,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 74,209,000
Free Cash Flow Per Share Twelve Trailing Months 0.17
Free Cash Flow Past Year -68,977,000
Free Cash Flow Prior Year 33,289,000

Options

Put/Call Ratio 1.52
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 2.46
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 10/20/2026 9:39:39 PM EST